Why is Fredun Pharma falling/rising?

As of 11-Sep, Fredun Pharmaceuticals Ltd's stock price is currently at 1,230.00, reflecting a decrease of 15.0 points or 1.2%. The stock has been underperforming recently, having fallen for three consecutive days, resulting in a total decline of 7.19% during this period. Although the stock opened with a gain of 2% today and reached an intraday high of Rs 1,300, it has still underperformed its sector by 1.67%. Over the past week, the stock has seen a decline of 3.15%, but it has performed well over the longer term, with a year-to-date increase of 66.84% and a one-year return of 55.68%. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the Sensex, which has gained 1.03% over the past week, Fredun Pharmaceuticals' short-term performance has lagged significantly. While the stock has shown impressive returns over the longer term, its recent decline contrasts with the broader market's upward trend. The stock's liquidity appears sufficient for trading, with a delivery volume increase noted, suggesting some investor interest despite the recent downturn. Overall, the stock's current struggles seem to be influenced by short-term market dynamics rather than a lack of long-term growth potential.